Postnatal adherent cells and preparation method therefor
AssigneeCha Biotech Co., Ltd.
InventorsHye Sun Kim, Ah Reum Kang, Hyun Ju Kim, Kung Mi Park, Sang Un Joo
Life of this patent
Estimating the term…
Abstract
Enhanced postnatal adherent cells and a preparation method therefor are provided. The preparation method of enhanced postnatal adherent cells can increase the yield and the proliferation rate of adherent cells from placental tissues; and prepare adherent cells, which secrete proteins effective for neurological diseases and have an improved ability for movement to damaged tissues.
Claims11
A method of preparing enhanced postnatal adherent cells, the method comprising:
- obtaining an amniotic tissue from a detached placenta;
- harvesting cell populations by adding an enzyme mixed solution to the amniotic tissue, wherein the enzyme mixed solution comprises collagenase at a concentration of 0.5 mg/ml to 5 mg/ml, trypsin at a concentration of 1 mg/ml to 5 mg/ml, DNA hydrolase (DNase) at a concentration of 0.01 mg/ml to 0.05 mg/ml, and dispase at a concentration of 0.1 U/ml to 5 U/ml;
- isolating the enhanced postnatal adherent cells by culturing the harvested cell populations in a container by adhesion culture and then treating the cell populations with an animal component-free (ACF) recombinant enzyme;
- and
- subculturing the isolated enhanced postnatal adherent cells under a hypoxia condition lower than a normoxia condition of 21% in a medium containing fibroblast growth factor-4 (FGF-4) and heparin at least 6 passages, wherein the subculturing further comprises treatment of the animal component-free recombinant enzyme before transferring the cells for subculturing at every stage of subculturing, and
- wherein 80% or more of the adherent cells express CD44, CD73, CD90, and CD105-positive surface markers and 10% or less thereof express a CD45-negative surface marker, and more vascular endothelial growth factor (VEGF) and interleukin-6 (IL-6) are secreted compared to the isolated enhanced postnatal adherent cells of passages 1 to 4.
A method of increasing a preparation efficiency of enhanced postnatal adherent cells, the method comprising:
- harvesting cell populations by adding an enzyme mixed solution to an amniotic tissue, wherein the enzyme mixed solution comprises collagenase at a concentration of 0.5 mg/ml to 5 mg/ml, trypsin at a concentration of 1 mg/ml to 5 mg/ml, DNA hydrolase (DNase) at a concentration of 0.01 mg/ml to 0.05 mg/ml, and dispase at a concentration of 0.1 U/ml to 5 U/ml;
- isolating enhanced postnatal adherent cells by culturing the harvested cell populations in a flask by adhesion culture and then treating the cell populations with an animal component-free (ACF) recombinant enzyme;
- and
- subculturing the isolated enhanced postnatal adherent cells under a hypoxia condition lower than a normoxia condition of 21% in a medium containing fibroblast growth factor-4 (FGF-4) and heparin at least 6 passages, wherein the subculturing further comprises treatment of the animal component-free recombinant enzyme before transferring the cells for subculturing at every stage of subculturing, and
- wherein 80% or more of the adherent cells express CD44, CD73, CD90, and CD105-positive surface markers and 10% or less thereof express a CD45-negative surface marker, and more vascular endothelial growth factor (VEGF) and interleukin-6 (IL-6) are secreted compared to the isolated enhanced postnatal adherent cells of passages 1 to 4.
Dependencies are inferred from the claim text.